The complex interplay between the response regulator ComA, the anti-activator RapF, and the signaling peptide PhrF controls competence development in Bacillus subtilis. More specifically, ComA drives the expression of genetic competence genes, while RapF inhibits the interaction of ComA with its target promoters. The signaling peptide PhrF accumulates at high cell density and upregulates genetic competence by antagonizing the interaction of RapF and ComA. How RapF functions mechanistically to inhibit ComA activity and how PhrF in turn antagonizes the RapF-ComA interaction were unknown. Here we present the X-ray crystal structure of RapF in complex with the ComA DNA binding domain. Along with biochemical and genetic studies, the X-ray crystal structure reveals how RapF mechanistically regulates ComA function. Interestingly, we found that a RapF surface mimics DNA to block ComA binding to its target promoters. Furthermore, RapF is a monomer either alone or in complex with PhrF, and it undergoes a conformational change upon binding to PhrF, which likely causes the dissociation of ComA from the RapF-ComA complex. Finally, we compare the structure of RapF complexed with the ComA DNA binding domain and the structure of RapH complexed with Spo0F. This comparison reveals that RapF and RapH have strikingly similar overall structures, and that they have evolved different, non-overlapping surfaces to interact with diverse cellular targets. To our knowledge, the data presented here reveal the first atomic level insight into the inhibition of response regulator DNA binding by an anti-activator. Compounds that affect the interaction of Rap and Rap-like proteins with their target domains could serve to regulate medically and commercially important phenotypes in numerous Bacillus species, such as sporulation in B. anthracis and sporulation and the production of Cry protein endotoxin in B. thuringiensis.
Upon phosphorylation, bacterial proteins called response regulators bind to DNA promoters and activate or repress transcription. These response regulators are themselves regulated by anti-activator proteins, which can control response regulator activity without altering their phosphorylation state. We have determined the X-ray crystal structure of the anti-activator RapF complexed with the DNA-binding domain of the response regulator ComA. Our structure-function studies show that RapF disrupts the binding of ComA to DNA using a two-pronged mechanism. First, a RapF surface mimics DNA, and this DNA-like surface binds to nearly all of the ComA DNA-binding residues, thus blocking ComA's interaction with DNA. Second, RapF inhibits ComA dimerization. RapF is also regulated by the PhrF peptide; we find that the RapF-ComA interaction surface is distant from the proposed PhrF binding site. Furthermore, we found that RapF undergoes a conformational change upon binding to PhrF, which likely causes its dissociation from ComA. From these observations, we conclude that PhrF binding to RapF allosterically triggers its dissociation from ComA. Finally, we compared the RapF/ComA DNA-binding domain complex structure with the structure of another response regulator, Spo0F, complexed with the phosphatase RapH. This reveals that while RapF and RapH are structurally similar, they have evolved distinct, non-overlapping surfaces to interact with their different cellular targets.
Citation: Baker MD, Neiditch MB (2011) Structural Basis of Response Regulator Inhibition by a Bacterial Anti-Activator Protein. PLoS Biol 9(12): e1001226. doi:10.1371/journal.pbio.1001226
Academic Editor: Ann Stock, UMDNJ/Robert Wood Johnson Medical School/HHMI, United States of America
Received: June 6, 2011; Accepted: November 14, 2011; Published: December 27, 2011
Copyright: © 2011 Baker, Neiditch. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by US National Institutes of Health (NIH) grant R01AI081736 to M.B.N and a UNCF-Merck Science Initiative Postdoctoral Fellowship to M.D.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: CTD, C-terminal domain; HTH, helix-turn-helix; NTD, N-terminal domain; REC, receiver; SE-AUC, sedimentation-equilibrium analytical ultracentrifugation; TPR, tetratricopeptide repeat
Two-component signaling systems, consisting of a sensor histidine kinase and a response regulator transcription factor, are the principal mechanism of signal transduction in bacteria . Upon phosphorylation of their receiver (REC) domains, response regulators bind target DNA promoters and activate or repress transcription. A number of auxiliary factors have garnered significant attention because they function as anti-activators that inhibit response regulator function without affecting their phosphorylation state. These proteins inhibit the interaction of response regulators with their target promoters – or RNA polymerase ,. To our knowledge, the X-ray crystallographic, biochemical, and genetic results presented here show for the first time how an anti-activator structurally inhibits the binding of a response regulator to DNA.
The Rap proteins are a family of auxiliary factors that have been most thoroughly studied in Bacillus subtilis, where they regulate two-component and phosphorelay signal transduction. Despite their relatively high sequence similarity, different Rap proteins exert their influence on these pathways via disparate activities . Rap proteins ultimately influence diverse B. subtilis developmental and cellular differentiation processes including sporulation, genetic competence, and biofilm formation, as well as the production of secreted enzymes and the movement of a conjugative transposon ,.
B. subtilis encodes 11 Rap proteins on its chromosome and another five on plasmids –. Rap proteins were named after the founding members of the family, which were shown to be response regulator aspartate phosphatases . Rap proteins including RapA, RapB, RapE, RapH, and RapJ are phosphatases that dephosphorylate the intermediate response regulator Spo0F, which consists solely of a REC domain ,–. In contrast, genetic and biochemical results show that a subset of Rap proteins, including RapC, RapF, and RapH, are anti-activators that bind to the response regulator transcription factor ComA, inhibiting its interaction with DNA promoters without affecting its phosphorylation state (Figure 1) ,,. Additional genetic results also suggest that RapD, RapG, and RapK may inhibit ComA as well –. Similarly, B. subtilis RapG inhibits the binding of the response regulator transcription factor DegU to its target promoters . Consistent with the inability of the Rap proteins to dephosphorylate ComA or DegU, it was previously shown that RapC, RapF, and RapH interact stably with the ComA helix-turn-helix (HTH) DNA binding domain and not with its REC domain ,.
Figure 1. The B. subtilis competence signal transduction pathway.
ComP autophosphorylates in response to binding the quorum-sensing signal ComX and subsequently phosphorylates ComA. ComA~P drives transcription of the srfA operon that in turn triggers the expression of late-stage competence genes. RapC, RapF, and RapH inhibit the binding of ComA to its target promoters, repressing the induction of genetic competence. Mature Phr peptides are generated proteolytically from pro-Phr proteins during export. The Spo0K permease (not pictured) imports Phr peptides into the cytoplasm where they antagonize Rap protein function. H, histidine; D, aspartic acid; P, phosphoryl group.doi:10.1371/journal.pbio.1001226.g001
Secreted signals called Phr peptides contribute to the complexity of Rap protein signaling. Phr peptides are imported into the cell, where they bind to Rap proteins and antagonize their activity (Figure 1) ,. Mature Phr peptides are generated from immature pro-Phr polypeptides ,. The genes encoding the pro-Phr polypeptides overlap with the 3′ end of the rap genes, forming rap-phr gene cassettes. Pro-Phr polypeptides are secreted from the cell and subsequently undergo proteolytic maturation. Mature Phr peptides are then imported into the cell, where each peptide inhibits its cognate Rap protein (e.g., PhrA inhibits RapA, and PhrC inhibits RapC) and in some cases a non-cognate Rap protein –.
To demonstrate how anti-activators such as the Rap proteins inhibit the binding of response regulators to target DNA promoters, we determined the X-ray crystal structure of a B. subtilis Rap protein, RapF, in complex with the DNA binding domain of the response regulator ComA (ComAC). As expected, comparison of the RapF-ComAC crystal structure with the previously determined structure of RapH-Spo0F  revealed that RapF and RapH are structurally similar; however, ComAC and Spo0F bind to RapF and RapH, respectively, at distinct, non-overlapping sites. Furthermore, we show that RapF is monomeric either alone or in complex with PhrF, and that RapF undergoes a conformational change upon binding PhrF that is likely the cause of ComA dissociation from RapF-ComA complexes. Finally, we propose a model that explains the long-standing observation that some Rap proteins dephosphorylate response regulator REC domains while others sequester response regulator HTH DNA binding domains.
Overall Structure of the RapF-ComAC Complex
To begin to determine how RapF inhibits response regulator binding to DNA without affecting its phosphorylation state, we solved its X-ray crystal structure in complex with ComAC to 2.30 Å resolution (Figure 2A and Table S1). The crystallographic asymmetric unit contains one molecule of RapF bound to one molecule of ComAC. It is worth noting that the RapF-ComAC crystallization conditions are identical to conditions that yield crystals in our initial screens containing RapF and full-length ComA (ComAFL). However, RapF-ComAFL crystals diffracted anisotropically and to very low resolution. Presumably, the ComA N-terminal REC domain, which does not interact with RapF , is responsible for the disorder observed in the RapF-ComAFL crystals.
Figure 2. RapF-ComAC structure.
(A) The RapF-ComAC crystallographic asymmetric unit. (B) RapF domain architecture with α-helices depicted as cylinders. HTH, helix-turn-helix. (C) RapF-ComAC oriented as in panel B and looking down the helical axis of the principal ComA DNA binding helix α9. RapF residues buried in the RapF-ComAC interface are colored magenta.doi:10.1371/journal.pbio.1001226.g002
RapF consists of two distinct domains, an N-terminal antiparallel 3-helix bundle (residues 7–72) and a C-terminal tetratricopeptide repeat (TPR) domain (residues 92–381) (Figure 2B). The RapF N-terminal 3-helix bundle consists of two similarly sized helices, α1 (residues 8–23) and α2 (residues 26–42), and a significantly longer third helix, α3 (residues 47–72). The 3-helix bundle and TPR domain are connected by an elaborate linker region (residues 73–91), containing a 310 helix (residues 75–77) joined by a short loop (residues 78–80) to helix α4 (residues 81–91). As discussed in detail below, the N-terminal 3-helix bundle and the linker region form the ComAC binding surface (Figures 2C, 3A, and 3B). The RapF C-terminal TPR domain contains seven helix-turn-helix (HTH) folds that assemble into a large superhelix. HTH folds 1–5 and 7 are bona fide TPR folds containing TPR signature sequences (Figure 2B) . The sixth HTH fold lacks the TPR signature motif but perpetuates the TPR superhelix. Therefore, we refer to the entire C-terminal region containing seven tandem HTH folds as the TPR domain.
Figure 3. In vitro and in vivo activity of RapF mutants targeting the RapF-ComA interface.
(A) RapF (blue cartoon) in complex with ComAC (brown surface). (B) Expanded view of the area enclosed by the black square in panel A. RapF residues targeted for in vitro or in vivo functional analysis are depicted as magenta sticks. (C) Native PAGE analysis of RapF-ComA complexes. (D) In vivo activity of RapF and RapF mutants targeting the RapF-ComA interface measured as a function of PsrfA-luc. The inset panel shows that the PsrfA-luc strains exhibited similar ComA activity in the absence of induced RapF. Each curve is representative of at least three independent experiments performed in duplicate. T0 is the time of transition from exponential growth to the stationary phase. Western blotting showed that RapF was overexpressed from the Pspank(hy) promoter at 2.5 times the level of endogenously produced RapF at T0 (unpublished data). RLU, Relative Luminescence Units.doi:10.1371/journal.pbio.1001226.g003
The RapF-ComAC X-ray crystal structure reveals an extensive protein-protein interface that buries a total of 1,845.7 Å2 surface area (Figures 3A and 4A). The structure of ComAC and its interaction with target binding sites within the srfA promoter were previously studied using NMR spectroscopy . The RapF-ComAC crystal structure shows that most of the ComA residues that interact with the DNA phosphate backbone, including Ser181, Ser184, Tyr187, Ser188, and Thr190, are buried in the RapF-ComAC interface (Figures 4B, 4C, and S1 and unpublished data). Furthermore, both of the ComA residues shown to interact with the DNA major groove, specifically Arg183 and Tyr187, are buried in the RapF interface (Figures 4C, S1, and S2).
Figure 4. In vitro binding of wild-type RapF to His-ComA mutants targeting the RapF-ComA interface.
(A) RapF (blue surface) in complex with ComAC (brown cartoon). (B) Expanded view of the area enclosed by the black rectangle in panel A. (C) RapF interaction with the principal ComA DNA binding helix α9 (brown helix). (D) The binding of wild-type RapF to His-ComA mutants corresponding to the residues depicted as magenta sticks in panels B and C was determined by native PAGE.doi:10.1371/journal.pbio.1001226.g004
In sum, the RapF-ComAC interaction buries six of the seven ComA DNA binding residues. It is also notable that in addition to interacting with ComA DNA binding residues, RapF mediates extensive interactions with ComAC residues not directly involved in DNA binding. As described in detail below, we rigorously tested the functional importance of the crystallographically observed RapF-ComAC interface both in vitro and in vivo.
Functional Analysis of the RapF-ComA Interface In Vitro
To begin to test the functional significance of the RapF-ComA interactions observed in the RapF-ComAC crystal structure, we generated RapF mutants containing individual alanine substitutions at RapF-ComA interfacial positions (Figures 3B and S1), and native PAGE was used to examine the binding of the RapF mutants to wild-type full-length ComA (Figure 3C). RapF Asp28 hydrogen bonds to the ComA Arg157 and Thr155 side chains, and RapF Leu67 forms a hydrophobic interaction with ComA Tyr187 (Figure S1). Consistent with these observations, RapF-D28A and RapF-L67A exhibited a complete loss of ComA binding activity (Figure 3C). Furthermore, RapF P27A forms a hydrophobic interaction with ComA Ile161 and Ser188, and RapF Gln78 hydrogen bonds with ComA Asn194 and with a water molecule at the RapF-ComA interface (Figure S1). Compared to the interaction of wild-type RapF with ComA, the interaction of RapF-P27A and RapF-Q78A with ComA was significantly reduced (Figure 3C).
In addition to the RapF mutants evaluated above, we analyzed the binding of RapF-F24A to wild-type ComA (Figure 3C). RapF Phe24 is located in the loop connecting RapF helices α1 and α2 (Figure 3B). Its main-chain carbonyl oxygen forms a hydrogen bond with the ComA Ser191 side-chain hydroxyl, and its carbonyl carbon atom mediates hydrophobic interactions with ComA Lys195 (Figure S1). Native gel analysis showed that the F24A mutation in RapF results in a complete loss of ComA binding (Figure 3C). While a portion of the RapF Phe24 side chain and main chain are buried in the ComA interface, the rest of its side chain is buried in a hydrophobic pocket formed by residues in RapF helices α3 and α4. We propose that the interaction of the RapF Phe24 side chain with RapF helices α3 and α4 is essential for the RapF-ComA interaction because it (1) positions the RapF Phe24 main chain carbonyl for interaction with ComA and (2) mediates the packing of the RapF 3-helix bundle and linker, which both in turn interact with ComA. Also consistent with this hypothesis, Phe24 is conserved in the Rap proteins previously shown to bind ComA directly ,,.
One RapF mutant, RapF-E71A, exhibited a significant but subtler ComA-binding defect than the other RapF mutants tested (Figures 3C and unpublished data). While RapF Glu71 mediates contacts with ComAC (Figure S1), it is located at the periphery of the RapF-ComA interface where it is exposed to bulk solvent. Consistent with previous studies of protein-protein interfaces (see, for example, ), interfacial residues such as RapF Glu71 that are exposed to bulk solvent routinely have little impact on the free energy of binding.
In addition to the RapF mutants described above, we engineered full-length ComA mutants containing single alanine substitutions at the RapF-ComAC interface (Figures 4A–C and S2). The binding of the ComA mutants was then evaluated using native PAGE (Figure 4D). ComA Arg183 forms a salt bridge with RapF Glu71 (Figures S1 and S2), and it also interacts intramolecularly with Tyr187, which is also in the RapF interface. ComA-R183A displayed a nearly complete loss of RapF binding, while numerous other ComA mutants, including ComA-Y187A, ComA-T190A, and ComA-N194A, displayed significantly reduced RapF binding activity compared to wild-type ComA (Figures 4D and S2). Only one mutant tested, ComA-R157A, appeared to bind RapF with a similar affinity to wild-type ComA (Figure 4D). As described above, ComA Arg157 and ComA Thr155 hydrogen bond to RapF Asp28 (Figure S1). ComA-T155A was insoluble and therefore could not be studied in vitro, but it is likely that the interaction of ComA Thr155 and RapF Asp28 is primarily responsible for the complete loss-of-function displayed by RapF-D28A (Figure 3C). Finally, we estimate based on the results of the qualitative analysis (Figures 3C and 4D) and additional native PAGE binding studies employing a broad concentration range of RapF and a fixed quantity of ComA (unpublished data) that the dissociation constant (Kd) for RapF-ComA complex formation is in the 1–10 µM range.
In Vivo Functional Analysis of the RapF-ComA Interface
To confirm that the RapF-ComA interface observed in the crystal structure is important for the regulation of ComA activity in vivo, we overexpressed RapF mutants containing single alanine substitutions in RapF-ComA interfacial positions and evaluated their affects on ComA transcriptional activity in B. subtilis (Figure 3D). More specifically, we measured RapF activity as a function of ComA-driven srfA transcription using the Photinus pyralis luciferase gene fused to the srfA promoter. As previously described, P. pyralis luciferase activity corresponds closely with the rate of its transcription in B. subtilis ,.
The PsrfA-luc reporter bioassay shows that srfA expression is delayed in proportion to the amount of RapF induced (Figure S3A). However, we questioned why srfA was expressed at all considering the fact that the cells overexpressed RapF, which inhibits ComA-driven srfA expression. We hypothesized that PhrF expressed from its endogenous locus (Figure S4) was antagonizing RapF activity. To confirm that this was the case, we overexpressed a RapF mutant, RapF-D194N, which contains a mutation previously shown to render RapA and RapC immune to the effects of their cognate Phr peptides ,. Indeed, overexpressed RapF-D194N completely suppressed PsrfA-luc expression throughout the course of the entire experiment (unpublished data). Moreover, when we added synthetic PhrF peptide to the PsrfA-luc reporter strain overexpressing RapF, PsrfA-luc expression was indistinguishable from the non-induced control (Figure S3B). Together, these results show that overexpressed RapF is antagonized at least to some degree by PhrF expressed from its endogenous locus. Nonetheless, overexpressing RapF significantly delays srfA-luc expression. Consistent with these results and as described below, strains overexpressing RapF proteins containing mutations in the RapF-ComA interface should express srfA-luc at earlier time points than the wild-type RapF control.
Mirroring the results of the RapF-ComA binding studies, RapF-D28A and RapF-L67A displayed a loss-of-function, and RapF-P27A and RapF-Q78A displayed intermediate phenotypes (Figure 3D). Also consistent with the in vitro results (Figures 3C), RapF-E71A displays a slight loss of function in vivo (Figure 3D). Western blotting confirmed that the RapF mutants were produced at levels comparable to wild-type RapF (unpublished data). Thus, the results of the RapF-ComA in vitro binding studies and the RapF-ComA luciferase bioassays show that the RapF-ComA interface identified in the RapF-ComAC crystal structure is functionally important in vitro and in vivo.
RapF dimerizes around a crystallographic 2-fold symmetry axis in the RapF-ComAC crystals. To begin to determine whether RapF also dimerizes in solution, we analyzed RapF and RapF-ComA complexes by gel filtration (Figure 5A). The results of these studies suggested that RapF alone and RapF in complex with ComA could be forming dimers in solution (Table 1). However, molecular weight determination using gel filtration becomes less reliable as the shape of the analyzed protein or protein complex deviates from that of a sphere, and RapF has an elongated structure (Figure 2A). In fact, RapF is approximately twice as long as it is wide, and its shape more closely resembles a rod than a sphere. Therefore, to determine unambiguously whether RapF dimerizes in solution, we studied RapF using sedimentation-equilibrium (SE) analytical ultracentrifugation (AUC). The theoretical molecular weight of a RapF monomer is 46.3 kD, and its molecular weight as determined by SE AUC is 47 kD (Figure 5B and Table 1). Therefore, we conclude that RapF is monomeric in solution.
Figure 5. Analysis of RapF complexes in solution.
(A) Size exclusion chromatography of RapF (peak elution volume (VR) 14.11 ml), ComA2 (VR 14.75 ml), and RapF-ComA (RapF-ComA VR 13.43 ml, uncomplexed ComA VR 14.80 ml). SDS-PAGE analyses of the indicated fractions are shown below the traces. The peak positions of gel filtration standards are indicated by vertical lines above the traces. (B) Sedimentation equilibrium data for 50 µM RapF (filled circles) and 50 µM RapF-ComA (open triangles). Centrifugation was carried out at 13,000 rpm (RapF) or 9,000 RPM (RapF-ComA) and 20°C as described in the Materials and Methods. Bottom, the measured absorbance at 286 nm (RapF) or 285 nm (RapF-ComA) versus the radius (distance to the center of the rotor) is shown. The continuous line represents the result from a single exponential fit of the data points. Top, the residuals to the fit expressed as the difference between experimental and fitted values. The residuals for the RapF-ComA sample deviated from zero in a systematic fashion, suggesting the presence of non-specific interactions probably between weakly associating ComA dimers in buffer A (see Materials and Methods). (C) Size exclusion chromatography of RapF as in panel A (VR 14.11 ml) and RapF+PhrF (VR 15.12 ml). SDS-PAGE analysis and peak positions of gel filtration standards are depicted as in panel A. (D) Sedimentation equilibrium data for 50 µM RapF (open circles) mixed with 500 µM PhrF. Top and bottom graphs are depicted as in panel B. Centrifugation was carried out at 13,000 rpm and 20°C as described in Materials and Methods. The absorbance was measured at 286 nm. (E) Size exclusion chromatography of RapF-ComA as in panel A (RapF-ComA VR 13.43 ml and uncomplexed ComA2 VR 14.80 ml) and RapF-ComA+PhrF (VR 15.06 ml). Due to their similar size, the RapF-PhrF and ComA2 peaks overlap. SDS-PAGE analysis and gel filtration standards are depicted similarly as in panel A. See Table 1 for the molecular weights calculated from the SEC and SE AUC shown in panels A–E. (F) Structural alignment of ComAC from the RapF-ComAC X-ray crystal structure with a molecule of the ComAC homodimer (2KRF) . The ComAC backbone atoms aligned with a root mean-square deviation of 1.40 Å. The dimerization interface consists primarily of residues in helix α10 and the α7–α8 loop. ComAC residues buried in the RapF-ComAC interface are colored green. For clarity, RapF is omitted.doi:10.1371/journal.pbio.1001226.g005
Table 1. Molecular weight (M) of ComA, RapF, RapF-ComA, and RapF-PhrF complexes determined by size exclusion chromatography (SEC) and analytical ultracentrifugation (AUC).doi:10.1371/journal.pbio.1001226.t001
The RapF-ComAC crystallographic asymmetric unit (Figure 2A) contains one molecule of RapF bound to one molecule of ComAC, suggesting that perhaps a monomer of RapF binds to a monomer of ComA in solution. However, ComA alone and ComAC alone homodimerize in solution (Figure 5A, Table 1) ,, and ComA dimers bind to DNA regulatory sites composed of three recognition elements . Therefore, we examined whether RapF is binding a ComA monomer or dimer in solution using gel filtration in combination with total amino acid analysis and SE AUC. A mixture of RapF and ComA was passed over a gel filtration column and total amino acid analysis was performed on the RapF-ComA complex fractions as described in Materials and Methods. The results of the total amino acid analysis (unpublished data) indicate that the stoichiometry of the RapF-ComA complex is 1:1. Finally, SE AUC analysis of the identical RapF-ComA sample indicated the formation of a single species of approximately 74 kD (Figure 5B). This is consistent with a complex composed of one molecule of RapF (45.7 kD) and one molecule of ComA (26.3 kD) (Table 1).
Together, the results of the SE AUC, gel filtration chromatography combined with total amino acid analysis, and X-ray crystallography suggest that a monomer of RapF binds to a monomer of ComA or ComAC, and that the stoichiometries of the RapF-ComA and RapF-ComAC complexes are 1:1. In Figure 5F, ComAC from the RapF-ComAC X-ray crystal structure is aligned with a molecule of ComAC from the dimeric ComAC NMR structure . While the RapF-ComAC structure shows that RapF-bound ComAC undergoes conformational changes near the ComAC dimerization interface, we cannot rule out the possibility that these changes were influenced by lattice contacts involving ComAC. Nonetheless, consistent with the RapF-ComAC crystal structure, we find that RapF binds to a ComA monomer in solution. Furthermore, while RapF does not interact with ComAC dimerization interface residues, which are located in helix α8, α10, and the α7–α8 loop (Figure 5F), we hypothesize that the RapF-induced ComAC conformational change is transmitted to ComA α10 through contacts between RapF and ComA residues in the C-terminus of α9 (residues N194 and K195) and the α9–α10 loop (residues N197, V198, and G199) (Figure 5F). In fact, RapF Gln78 and RapF Phe24 contact ComA Asn194 and Lys195, respectively, and RapF-Q78A and RapF-F24A both exhibited severe ComA binding defects (Figure 3C). Despite the numerous contacts between RapF and ComA residues directly adjacent to the ComAC dimerization interface, because RapF does not interact with the surface of the ComAC dimerization interface, we conclude that RapF allosterically inhibits ComAC dimerization.
RapF Undergoes a Conformational Change Upon Binding to PhrF
The gel filtration analysis of RapF-ComA and RapF performed above (Figure 5A) were repeated in the presence of PhrF (Figure 5C, 5E and Table 1). Consistent with previous native-PAGE studies , we found that PhrF caused the dissociation of the RapF-ComA complex (Figure 5E and Table 1). Also consistent with these native-PAGE studies where a faster migrating RapF band was observed in the presence of PhrF, we found that PhrF caused RapF to elute at a significantly higher volume than RapF alone (Figure 5C, 5E, and Table 1). However, in the previous native PAGE studies it was assumed that RapF was dimeric , and why a faster migrating band appeared in the presence of PhrF was unknown.
As discussed above, SE AUC shows that RapF alone is monomeric (Figure 5B and Table 1). Consistent with this result, the molecular weight of RapF complexed with PhrF is 50 kD as determined by SE AUC (Figure 5D and Table 1), and there is no change in RapF stoichiometry upon binding to PhrF. Therefore, we conclude that RapF migrates through the gel filtration matrix radically slower in the presence of PhrF than in its absence, and RapF migrates faster in the presence of PhrF when analyzed by native PAGE , because it undergoes a large conformational change upon binding to PhrF.
Response regulators are the primary mechanism for converting sensory perception into transcriptional output in bacteria. How auxiliary factors such as the Rap proteins function structurally to inhibit response regulator binding to DNA promoters was not known. The X-ray crystallographic, biochemical, and genetic results presented here reveal that RapF disrupts response regulator binding to DNA using a two-pronged mechanism. First, RapF buries ComA DNA binding residues in the RapF-ComA interface, sterically blocking the binding of ComA to its DNA recognition elements. Second, RapF binding allosterically weakens the ComAC dimerization interface, inhibiting the formation of transcriptionally active ComA dimers (Figure 5B). In theory, each mechanism alone could effectively inhibit response regulator activity; however, RapF uses both.
To our knowledge, the data presented here reveal the first atomic level insight into the inhibition of response regulator DNA binding by an anti-activator. However, the structures or regulatory mechanisms of other anti-activators and anti-repressors that target transcription factors other than response regulators have been described, for example TraM, CarS, TrlR, AppA, and ExsD (Figure S5) –. These proteins repress the activity of their targets by (1) directly blocking the interaction of DNA binding residues and DNA, (2) inhibiting their functionally required multimerization, or (3) causing allosteric rearrangements that preclude their binding to DNA. RapF does not share obvious structural similarities with these anti-activators and anti-repressors (Figure S5); however, a comparison of the structural and functional data available for the different systems is informative.
The TraR-TraM crystal structure showed that the anti-activator TraM interacts with the TraR N-terminal dimerization domain (NTD) in addition to its C-terminal DNA binding domain (CTD) and linker region connecting the NTD and CTD (Figure S5) . In contrast to the interactions observed in the RapF-ComAC structure, TraM does not contact the TraM DNA binding residues. Rather, TraM allosterically regulates TraR activity.
CarS-CarA interactions were mapped using NMR chemical shift perturbation and site-directed mutagenesis studies . Interestingly, like RapF (discussed below), the anti-repressor CarS mimics DNA to interact with its target's DNA binding domain; however, the RapF and CarS folds are entirely different (Figure S5). While RapF is entirely alpha helical, CarS resembles an SH3 domain and consists of an antiparallel beta sheet and a 310 helix.
How TrlR, AppA, and ExsD function structurally to regulate their targets is not as well understood as it is for the systems discussed above. However, it was shown that TrlR is a truncated form of TraR that regulates TraM by forming inactive TrlR-TraR dimers , and that the flavin binding protein AppA inhibits PpsR repressor activity by reducing a disulphide bond in PpsR and forming inactive AppA-PpsR2 complexes . Finally, how ExsD functions structurally to inhibit ExsA transcriptional activity is unknown, and different studies suggest that ExsD interacts stably with either the ExsA N-terminal oligomerization domain alone  or only the intact full-length protein .
ComA is a member of the LuxR/FixJ/NarL family of transcriptional regulators whose HTH DNA-binding domains are tetra-helical bundles ,. Aligning ComAC of the RapF-ComAC structure with a molecule of NarLC of the NarLC-DNA complex structure (1JE8) revealed that RapF's ComA-binding surface adopts a conformation reminiscent of a DNA major groove (Figure 6A and 6B) ,. Additionally, analogous to DNA, at the core of the RapF ComAC-binding surface, there is a large electronegative patch (Figure 6C) . Moreover, six of the seven previously identified ComA DNA binding residues are buried in the RapF-ComAC interface. For example, the sidechain of ComA Arg183 forms a salt bridge with the side chain of RapF Glu71, and the side chain of ComA Thr190 forms a hydrogen bond with the side chain of RapF Glu71 (Figure S2). These contacts appear to mimic the hydrogen bonds that the ComA residues make with the DNA major groove and phosphate backbone, respectively . Thus, the RapF-ComAC X-ray crystal structure reveals that ComA binds to a RapF surface that, at least in part, mimics DNA.
Figure 6. RapF mimics DNA.
(A) Structural alignment of ComAC of the RapF-ComAC structure with a molecule of NarLC of the NarLC-DNA structure (1JE8)  oriented looking down the helical axis of ComAC helix α9 shows that the RapF ComA binding surface (magenta) resembles the shape of the DNA major groove. The ComAC and NarLC Cα backbone atoms aligned with a root mean-square deviation of 0.60 Å. (B) Top view of the alignment shown in panel A obtained by rotating panel A 90° in the direction indicated by the arrow. (C) The RapF electrostatic surface potential was calculated using APBS  and displayed on the solvent-accessible surface. Electronegative and electropositive surfaces are colored red and blue, respectively, and contoured from −5 to +5 kT/e. (D) B. subtilis LuxR/FixJ/NarL-type family member HTH DNA binding domain amino acid sequence alignment. Highly conserved residues are indicated with blue type. ComA secondary structure assignments are denoted by the black rectangles above the sequences. ComA residues buried in the RapF interface are indicated with red type. Asterisks and colons above the sequences denote ComA DNA binding residues and ComAC dimerization interface residues, respectively .doi:10.1371/journal.pbio.1001226.g006
HTH DNA binding domains are ubiquitous in all three superkingdoms of life . In fact, B. subtilis alone encodes 10 proteins containing tetra-helical bundle HTH domains similar to the ComA DNA binding domain . The identity of residues in helix α9 and the α8–α9 loop are primarily responsible for determining LuxR/FixJ/NarL-type HTH DNA recognition element specificity ,,,. For example, ComA Tyr187 in helix α9 inserts into the DNA major groove and contacts the phosphate backbone , while no other B. subtilis response regulator encodes tyrosine at the equivalent position (Figure 6D). Similarly, ComA Arg183 and Thr190 insert into the DNA major groove and contact the phosphate backbone, respectively. Only one other B. subtilis response regulator, YdfI, encodes identical residues at these positions (Figure 6D). YdfI is in fact the B. subtilis protein containing a LuxR/FixJ/NarL-type HTH domain most highly homologous to ComAC, yet they bind to different DNA recognition elements ,. Interestingly, we found that purified RapF and YdfI did not stably interact (unpublished data). We propose that Rap protein interactions with the HTH DNA binding residues serve to sterically block the binding of response regulators with their DNA recognition elements. Contacts with these DNA binding residues may enable Rap proteins to preferentially recognize their response regulator targets, e.g. ComA or DegU, among the myriad B. subtilis HTH DNA binding domains.
Some Bacillus Rap proteins are phosphatases that bind to and dephosphorylate Spo0F, a stand-alone REC domain, while others bind to the HTH DNA binding domain of the response regulator ComA rather than its REC domain ,,. Structural alignment of RapF of the RapF-ComAC structure with RapH of the RapH-Spo0F structure (3Q15) showed that their tertiary structures are essentially identical, and they align with a root mean-square deviation of 1.61 Å (Figure 7A–C) . Remarkably, this alignment also revealed that ComAC and Spo0F bind to non-overlapping Rap protein surfaces (Figure 7C). ComAC interacts only with the RapF linker region and 3-helix bundle, while Spo0F interacts with the RapH TPR domain and 3-helix bundle at a site distant from the ComAC binding site on the RapF 3-helix bundle.
Figure 7. ComAC and Spo0F bind to different Rap protein surfaces.
(A) Side view of the RapF-ComAC complex. (B) Side view of the RapH-Spo0F complex (3Q15) . This view was obtained by aligning RapH of the RapH-Spo0F complex with RapF of the RapF-ComAC complex as oriented in panel A and as described in (C). Dashed lines denote the RapH disordered region as described below. A comparison of panels A and B shows that ComAC and Spo0F bind to opposite faces of the RapF and RapH 3-helix bundles, respectively, and that Spo0F also interacts with the RapH TPR domain. (C) Side view of RapF of the RapF-ComAC structure aligned with RapH of the RapH-Spo0F structure. The RapF and RapH Cα backbone atoms aligned with a root mean-square deviation of 1.61 Å. We previously observed insufficient electron density corresponding to RapH residues 69–76, and they were not included in the RapH-Spo0F model . These residues correspond to the C-terminus of RapF helix α3 and a portion of the RapF linker region including the 310 helix. This region appears to be ordered in the RapF structure resulting from extensive interactions with ComA. Structural alignment of RapF of the RapF-ComAC structure with RapH of the RapH-Spo0F structure also revealed conformational differences in the regions surrounding the RapF and RapH α2–α3 loops. This area contains residues particularly important for Rap phosphatase activity, including a catalytic residue that inserts into the Spo0F active site. Thus, the conformational differences between RapF and RapH near the α2–α3 loop likely result from Spo0F binding to RapH.doi:10.1371/journal.pbio.1001226.g007
Rap proteins have not been observed to bind simultaneously to both the REC and HTH DNA binding domains of a single response regulator. However, it is possible that an ancestral Rap protein did in fact interact with both domains. The Spo0F (REC) and ComAC (HTH) binding sites do not overlap, and a Rap protein could theoretically bind to both a REC and HTH domain concurrently (Figure 7C). Alternatively, there may not have been an ancestral Rap protein that could bind a REC and HTH DNA binding domain. In this case, the fact that Rap proteins commonly target one or the other of two domains found in response regulator transcription factors could be a coincidence resulting from independent evolution of Rap protein interactions with their targets.
Furthermore, we speculate that Rap proteins such as RapC, RapF, and RapH may have evolved to interact stably with the ComA HTH domain but not its REC domain , because the short linker connecting them precludes their simultaneous interaction with the relevant Rap protein binding sites. Indeed, structural alignment of RapF of the RapF-ComAC structure with RapH of the RapH-Spo0F structure shows that the C-terminus of Spo0F and the N-terminus of ComAC are separated by greater than 49 Å. Rap proteins could interact with the REC and HTH domain of a single response regulator simultaneously if the domains were connected by a long linker as found in the B. subtilis uncharacterized protein YesN, or an additional domain common to the response regulators in the NtrC family ,. However, the relatively short linker region connecting the ComA REC and HTH domains would prevent their simultaneous interaction with the identified Rap protein REC  and HTH domain binding sites (Figure 7C).
Previous work suggests that Phr peptides may bind to the Rap protein TPR domain ,,, and it was hypothesized that response regulators may compete with Phr peptides for binding to a common site on the TPR domain . However, the RapF-ComAC X-ray crystal structure shows that the RapF TPR domain does not in fact contact ComAC. RapF-ComAC contacts are mediated only by the RapF 3-helix bundle and linker region. Thus, it appears that PhrF may allosterically inhibit the RapF-ComA interaction, and the dissociation of RapF and ComA presumably results from the PhrF-induced conformational change in RapF (Figure 5C and 5E). The Rap protein conformational changes induced by Phr peptide binding are currently unknown, and it seems likely that crystal structures of Rap proteins in their Phr peptide bound conformations will be required to reveal these conformational changes as well as the mechanistic nature of the Rap-Phr interaction.
Furthermore, in regard to Rap protein stoichiometry, it is worth noting that RapH dimerizes around a crystallographic 2-fold symmetry axis similar to RapF, and both RapH and RapK migrate through gel filtration matrix in a manner consistent with that of a dimer ( and unpublished data). However, SE AUC analysis of both RapH and RapK (unpublished data) show that they are in fact monomeric in solution like RapF. Additional SE AUC studies are required to determine whether other Rap proteins are monomeric similar to RapF, RapH, and RapK, or whether they are dimeric as previously suggested .
The results of our X-ray crystallographic studies, SE AUC, and gel filtration combined with total amino acid analysis suggest that a RapF monomer binds to a monomer of ComA or ComAC. However, the reported ComAC homodimerization interface residues  are not buried in the RapF-ComA interface (Figure 5F). Thus, it is theoretically possible that a molecule of ComA in a RapF-ComA complex could bind to another molecule of ComA using its ComAC homodimerization surface. Also, a molecule of ComA bound to RapF could bind to another molecule of ComA using its N-terminal receiver domain, which might be accessible because it does not interact stably with RapF. However, even if ComA can in fact homodimerize to some extent when bound to RapF, it is in all likelihood a non-functional ComA dimer. That is, if each molecule of ComA in a ComA dimer is required to interact with DNA at a target promoter , then RapF would disable the ComA dimer when it binds directly to and buries nearly all of the DNA binding residues belonging to one molecule of ComA.
Rap proteins are proposed to be the most ancient member of the RNPP protein family . The RNPP proteins are related to the Bacillus Rap, NprR, and PlcR proteins, as well as the Enterococcal protein PrgX. These proteins are widespread in Firmicutes, and a rap-phr cassette was also recently identified outside of the Firmicute phylum encoded on a plasmid in a highly multidrug resistant strain of Salmonella enterica serovar Dublin . Structure-function analysis showed that PlcR and PrgX are transcription factors that contain N-terminal DNA binding domains and C-terminal TPR or TPR-like domains ,. There are no structural data and very limited functional data available describing the NprR proteins, which include a number of proteins in Bacillus and Clostridia. Like PlcR and PrgX, NprR proteins are transcription factors; however, sequence analysis suggests that NprR proteins are essentially Rap proteins containing a tetrahelical bundle HTH DNA binding domain fused to their N-terminus .
We hypothesize that the NprR structure may closely resemble the structure of RapF-ComAC, except that in the case of NprR the HTH DNA binding domain is covalently attached to the N-terminus of the NprR 3-helix bundle. Similar to RapF-ComAC, DNA binding residues in the NprR HTH DNA binding domain may be buried in an interface with the NprR 3-helix bundle and linker region. Like the Rap proteins, NprR, PlcR, and PrgX activity is regulated by oligopeptides reminiscent of the Phr peptides (review in ). Peptide binding to NprR could disrupt the interaction of the NprR 3-helix bundle and its DNA binding domain, triggering NprR transcriptional activity. This mechanism is analogous to the PhrF-driven dissociation of the RapF 3-helix bundle and ComA.
In conclusion, we speculate that a protein containing only the Rap protein 3-helix bundle and linker region may be sufficient to inhibit the binding of HTH DNA binding domains to DNA. Engineering this relatively simple scaffold to bind HTH domains other than those belonging to ComA or DegU would create useful in vivo tools for studying bacterial signaling. Furthermore, Rap-Phr and NprR-Phr systems regulate medically and commercially important phenotypes in numerous Bacillus species, e.g. sporulation in B. anthracis  and sporulation and the production of Cry protein endotoxin in B. thuringiensis ,, respectively. Therefore, compounds that regulate the activity of Rap and Rap-like proteins could serve as commercially important additives that modulate the overproduction of insecticidal endotoxins or as antibacterial drugs.
Materials and Methods
Protein Purification for Crystallization
RapF was overexpressed as an N-terminal fusion to glutathione S-transferase (GST) in E. coli strain BL21 grown in LB media supplemented with 100 µg/ml ampicillin. The cultures were first grown at 37°C to an OD600 of 0.4 and then transferred to 25°C and induced with 0.1 mM isopropyl β-D-thiogalactopyranoside (IPTG) at an OD600 of 0.6. After growth for an additional 16 h at 25°C, cultures were harvested by centrifugation at 4,000 RPM, lysed in Buffer I (20 mM Tris pH 8.0, 150 mM NaCl, 5 mM DTT) supplemented with 5 mM MgCl2, 20 µg/ml DNaseI, and 2 mM phenylmethylsulfonyl fluoride (PMSF), and insoluble material pelleted at 22,000 RPM for 90 min. Cleared lysates were applied to Glutathione-Uniflow Resin (Clontech), equilibrated in Buffer I. The resin was then washed with Buffer I, resuspended in 4 bed volumes of Buffer I and 3.5 µg/ml thrombin, and incubated for 1.5 h at 25°C. This procedure resulted in complete cleavage of the N-terminal GST affinity tag as determined by SDS-PAGE. Following thrombin cleavage, RapF (residues 1–381) contained two heterologous residues (Gly-Ser) derived from the thrombin cleavage signal. RapF was eluted with Buffer I and diluted 2-fold with Buffer II (20 mM Tris pH 8.0, 5 mM DTT), passed through a 0.22 µm filter, and loaded onto an anion exchange column (Source 15Q, GE Healthcare) equilibrated with Buffer II containing 75 mM NaCl. RapF was eluted in a 75–750 mM NaCl linear gradient of Buffer II. RapF-containing fractions were further purified by gel filtration using a Superdex 200 (GE Healthcare) 16/70 column equilibrated with Buffer II containing 150 mM NaCl. Again, RapF containing fractions were pooled and concentrated.
ComAC protein (His-ComAC) was purified as described previously with the following modifications to the protocol . Following Ni-NTA affinity column chromatography, His-ComAC containing fractions were pooled, diluted 4-fold with Buffer III (50 mM Tris pH 8.0, 5 mM DTT), passed through a 0.22 µm filter, and loaded onto an anion exchange column (Source 15Q; GE Healthcare) equilibrated with Buffer III containing 50 mM KCl. His-ComAC eluted from the anion exchange column in the flow through and was concentrated by ultrafiltration (MWCO: 3 kDa). For storage, His-ComAC was exchanged into Buffer IV (50 mM 4-(2-Hydroxyethyl)-1-piperazinepropanesulfonicacid (EPPS) pH 8.0, 200 mM KCl, 1 mM DTT) using G-25-50 Sephadex (Sigma).
Crystallization and Data Collection
RapF-ComAC crystals were produced by the vapor diffusion method at 20°C using a 1:1 mixture of RapF:ComAC (100 µM RapF and ComAC each in its corresponding storage buffer) and well solution (6% [w/v] PEG 8,000, 240 mM calcium acetate, 80 mM sodium cacodylate pH 6.5, and 20% glycerol). Data were collected at a wavelength of 1.0750 Å on nitrogen-cooled crystals at NSLS beamline X29A. Diffraction data were processed using HKL2000 .
Structure Determination, Model Building, and Refinement
The RapF-ComAC structure was determined by molecular replacement with PHASER  using the N-terminal domain (residues 4–68) and C-terminal domain (residues 77–376) of RapH (3Q15) as search models . ComAC was not included in the search model. The single molecular replacement solution identified using PHASER was refined in REFMAC5 . ARP/wARP was used to generate an initial model , and iterative cycles of building in COOT  and refinement in PHENIX  were performed to complete the model. The final model lacks only residues 1–5 corresponding to the N-terminus of RapF, and 146–152 and 211–214 corresponding to the N- and C-terminus of ComAC, respectively. The building of a single Mn2+ atom into clear electron density during the final stages of refinement in PHENIX was justified based on its coordination to oxygen ligands, i.e. the carbonyl oxygens of RapF Leu40 and Met43, and the side chain oxygens in the RapF Glu45 side chain, the metal-oxygen ligand distances, the similarity of the Mn2+ refined B-factor to those of its surrounding atoms, and the absence of calculated Fo-Fc difference density surrounding the Mn2+ ion. Mn2+ was not added to the RapF purification or crystallization buffers and may have been acquired through adventitious buffer contamination. Secondary structure assignments were calculated using PROMOTIF . Ramachandran statistics were calculated in Molprobity . Molecular graphics were produced with PyMOL . The RapF-ComAC structure has excellent geometry, with 98.4%, 1.6%, and 0% of residues falling within the favored, allowed, and outlier regions of the Ramachandran plot, respectively.
Non-Denaturing Polyacrylamide Gel Electrophoresis
10 µM RapF and either 10 µM ComA or 10 µM His-ComA as indicated were incubated in Buffer A (20 mM Tris pH 8.0, 300 mM NaCl, 5 mM MgCl2, 1 mM DTT, and 5% glycerol) for 30 min at 4°C (see Text S1 for additional details regarding the purification of ComA and His-ComA). 5× sample buffer was added to each reaction mixture and samples were analyzed by native PAGE using 12% Tris-glycine gels. Gels were run under constant voltage (85 V) for 4 h at 4°C and then stained with Coomassie Brilliant Blue R-250 (Amresco). The disappearance of the lower band (ComA) was the primary indicator of complex formation. The degree of top band (RapF) shifting corresponded with the disappearance of ComA and provided additional evidence of RapF-ComA complex formation.
Gel filtration runs were performed with RapF, His-ComA, and PhrF (NH2-QRGMI-COOH) (LifeTein) at 20 µM, 40 µM, and 200 µM, respectively. Prior to analysis, the proteins were incubated in Buffer A for 30 min at 4°C and filtered by centrifugation through a 0.22 µm cut-off cellulose acetate filter (Spin-X; Costar). 100 µl of each sample was injected onto a Superdex 200 HR10/30 gel filtration column (Amersham Biosciences) equilibrated in Buffer A. 0.5 ml fractions were collected and analyzed by SDS-PAGE. Gels were stained with Coomassie Brilliant Blue R-250. RapF-ComA was prepared for total amino acid analysis by injecting a mixture containing 40 µM RapF and 80 µM His-ComA in Buffer A onto a Superdex 200 HR10/30 gel filtration column and collecting fractions spanning 12.0 to 13.5 ml as shown in Figure 5A. The RapF and ComA bands were separated by SDS-PAGE and excised for total amino acid analysis at the Keck Biotechnology Resource Laboratory (Yale).
Sedimentation Equilibrium Analysis
Analytical ultracentrifugation measurements were carried out on a Beckman XL-A (Beckman Coulter) analytical ultracentrifuge equipped with an An-60 Ti rotor (Beckman Coulter) at 20°C. 50 µM RapF and 50 µM RapF mixed with 500 µM PhrF were dialyzed overnight against 20 mM Tris pH 8.0 and 150 mM NaCl and analyzed at rotor speeds of 13,000 (Figure 5B) and 16,000 rpm (unpublished data). RapF-ComA Superdex 200 HR10/30 gel filtration fractions spanning 12.0 to 13.5 ml as shown in Figure 5A were dialyzed overnight against Buffer A minus DTT and analyzed at rotor speeds of 9,000 rpm (Figure 5D) and 16,000 rpm (unpublished data). Data were acquired at two wavelengths per rotor speed setting and processed simultaneously with a nonlinear least squares fitting routine . Solvent density and protein partial specific volume were calculated according to solvent and protein composition, respectively .
Luciferase assays were performed as previously described with the following modifications . The PsrfA-luc reporter strains (see Text S1) were grown in LB medium to an OD600 of 2.0, centrifuged, and resuspended in fresh Competence Medium (CM)  to an OD600 of 2.0. The cultures were then diluted 20-fold in fresh CM supplemented with 0.25 µM IPTG to induce expression of wild-type or mutant rapF from the Pspank(hy) promoter. 200 µl of the induced cultures were dispensed per well in duplicate in a 96-well black plate (Corning). Luciferin was added to each well at a final concentration of 0.47 µM. The cultures were then incubated at 37°C under agitation in a PerkinElmer Envision 2104 Multilabel Reader. The plate lids were heated to 38°C to avoid condensation. Relative Luminescence Unit (RLU) and OD600 were measured at 1.78 min intervals.
Atomic coordinates and structure factors for RapF-ComAC have been deposited in the Protein Data Bank under accession code 3ULQ.
Schematic representation of the RapF residues targeted for mutagenesis and their interactions at the ComA interface. RapF and ComA residues are depicted with blue and brown bonds, respectively. Hydrogen bonds are depicted as dashed green lines. Blue and brown semicircles with radiating lines depict hydrophobic contacts between RapF and ComA residues, respectively. The schematic was produced with LIGPLOT .
Schematic representation of the ComA residues targeted for mutagenesis and their interactions at the RapF interface. ComA and RapF residues are depicted with brown and blue bonds, respectively. Hydrogen bonds are depicted as dashed green lines. Brown and blue semicircles with radiating lines depict hydrophobic contacts between ComA and RapF residues, respectively. The schematic was produced with LIGPLOT .
RapF and PhrF regulate the expression of PsrfA-luciferase. (A) PsrfA-luc activity measured in the absence or presence of IPTG at the indicated concentrations. (B) Synthetic PhrF peptide added to the cultures antagonizes the delayed expression of PsrfA-luc caused by the overexpression of RapF.
B. subtilis upregulates the expression of phrF during the transition to stationary phase growth (T0). PhrF-luc expression in B. subtilis growing in competence media (CM) or sporulation media (DSM). In addition to being driven by a promoter upstream of the rapF-phrF operon, phrF expression is upregulated during stationary phase by the stationary phase sigma factor, σH, whose binding site lies within rapF .
The structures of (A) RapF-ComAC (PDB 3ULQ), (B) TraR-TraM (2Q0O) , (C) CarS (2KSS) , (D) the AppA BLUF domain (2IYG) , and (E) ExsD (3FD9) . To our knowledge the TrlR structure has not yet been determined; however, TrlR is a truncated form of TraR (panel B) .
Data collection and refinement statistics. Rsym = Σh Σi | Ii(h)−<I(h)>|/Σh Σi Ii(h), where Ii(h) is the ith measurement of h and <I(h)> is the mean of all measurements of I(h) for reflection h. Rwork = Σ ||Fo|−|Fc||/Σ |Fo|, calculated with a working set of reflections. Rfree is Rwork calculated with only the test set (5.1%) of reflections. Data for the highest resolution shell are given in parentheses. The structure was determined using a single crystal.
Supplemental Materials and Methods.
We gratefully acknowledge Nicolas Mirouze for providing the B. subtilis PsrfA-luc strain; David Dubnau, Frederick Hughson, Min Lu, David Kaback, Vijay Parashar, and Atul Khataokar for critical review of the manuscript; Phil Jeffrey, Nicolas Mirouze, and Miguel Dias for technical advice and discussion; Min Lu for equilibrium analytical ultracentrifugation; and anonymous referees for insightful suggestions. X-ray diffraction data were collected at the National Synchrotron Light Source beamline X29A.
The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: MDB MBN. Performed the experiments: MDB. Analyzed the data: MDB MBN. Contributed reagents/materials/analysis tools: MDB MBN. Wrote the paper: MDB MBN.
- 1. Gao R, Stock A. M (2009) Biological insights from structures of two-component proteins. Annu Rev Microbiol 63: 133–154.
- 2. Bongiorni C, Ishikawa S, Stephenson S, Ogasawara N, Perego M (2005) Synergistic regulation of competence development in Bacillus subtilis by two Rap-Phr systems. J Bacteriol 187: 4353–4361.
- 3. Core L, Perego M (2003) TPR-mediated interaction of RapC with ComA inhibits response regulator-DNA binding for competence development in Bacillus subtilis. Mol Microbiol 49: 1509–1522.
- 4. Ogura M, Shimane K, Asai K, Ogasawara N, Tanaka T (2003) Binding of response regulator DegU to the aprE promoter is inhibited by RapG, which is counteracted by extracellular PhrG in Bacillus subtilis. Mol Microbiol 49: 1685–1697.
- 5. Smits W. K, Bongiorni C, Veening J. W, Hamoen L. W, Kuipers O. P, et al. (2007) Temporal separation of distinct differentiation pathways by a dual specificity Rap-Phr system in Bacillus subtilis. Mol Microbiol 65: 103–120.
- 6. Ansaldi M, Theraulaz L, Mejean V (2004) TorI, a response regulator inhibitor of phage origin in Escherichia coli. Proc Natl Acad Sci U S A 101: 9423–9428.
- 7. Gora K. G, Tsokos C. G, Chen Y. E, Srinivasan B. S, Perchuk B. S, et al. (2010) A cell-type-specific protein-protein interaction modulates transcriptional activity of a master regulator in caulobacter crescentus. Mol Cell 39: 455–467.
- 8. Auchtung J. M, Lee C. A, Monson R. E, Lehman A. P, Grossman A. D (2005) Regulation of a Bacillus subtilis mobile genetic element by intercellular signaling and the global DNA damage response. Proc Natl Acad Sci U S A 102: 12554–12559.
- 9. Lopez D, Kolter R (2010) Extracellular signals that define distinct and coexisting cell fates in Bacillus subtilis. FEMS Microbiol Rev 34: 134–149.
- 10. Gleave A. P, Mountain A, Thomas C. M (1990) Use of a novel cassette to label phenotypically a cryptic plasmid of Bacillus subtilis and map loci involved in its stable maintenance. J Gen Microbiol 136: 905–912.
- 11. McLoon A. L, Guttenplan S. B, Kearns D. B, Kolter R, Losick R (2011) Tracing the domestication of a biofilm-forming bacterium. J Bacteriol 193: 2027–2034.
- 12. Meijer W. J, Wisman G. B, Terpstra P, Thorsted P. B, Thomas C. M, et al. (1998) Rolling-circle plasmids from Bacillus subtilis: complete nucleotide sequences and analyses of genes of pTA1015, pTA1040, pTA1050 and pTA1060, and comparisons with related plasmids from gram-positive bacteria. FEMS Microbiol Rev 21: 337–368.
- 13. Perego M, Hanstein C, Welsh K. M, Djavakhishvili T, Glaser P, et al. (1994) Multiple protein-aspartate phosphatases provide a mechanism for the integration of diverse signals in the control of development in B. subtilis. Cell 79: 1047–1055.
- 14. Jiang M, Grau R, Perego M (2000) Differential processing of propeptide inhibitors of Rap phosphatases in Bacillus subtilis. J Bacteriol 182: 303–310.
- 15. Parashar V, Mirouze N, Dubnau D. A, Neiditch M. B (2011) Structural basis of response regulator dephosphorylation by rap phosphatases. PLoS Biol 9: e1000589. doi:10.1371/journal.pbio.1000589.
- 16. Auchtung J. M, Lee C. A, Grossman A. D (2006) Modulation of the ComA-dependent quorum response in Bacillus subtilis by multiple Rap proteins and Phr peptides. J Bacteriol 188: 5273–5285.
- 17. Hayashi K, Kensuke T, Kobayashi K, Ogasawara N, Ogura M (2006) Bacillus subtilis RghR (YvaN) represses rapG and rapH, which encode inhibitors of expression of the srfA operon. Mol Microbiol 59: 1714–1729.
- 18. Ogura M, Fujita Y (2007) Bacillus subtilis rapD, a direct target of transcription repression by RghR, negatively regulates srfA expression. FEMS Microbiol Lett 268: 73–80.
- 19. Perego M, Brannigan J. A (2001) Pentapeptide regulation of aspartyl-phosphate phosphatases. Peptides 22: 1541–1547.
- 20. Pottathil M, Lazazzera B. A (2003) The extracellular Phr peptide-Rap phosphatase signaling circuit of Bacillus subtilis. Front Biosci 8: d32–d45.
- 21. Lanigan-Gerdes S, Dooley A. N, Faull K. F, Lazazzera B. A (2007) Identification of subtilisin, Epr and Vpr as enzymes that produce CSF, an extracellular signalling peptide of Bacillus subtilis. Mol Microbiol 65: 1321–1333.
- 22. Stephenson S, Mueller C, Jiang M, Perego M (2003) Molecular analysis of Phr peptide processing in Bacillus subtilis. J Bacteriol 185: 4861–4871.
- 23. Lazazzera B. A, Solomon J. M, Grossman A. D (1997) An exported peptide functions intracellularly to contribute to cell density signaling in B. subtilis. Cell 89: 917–925.
- 24. Perego M (1997) A peptide export-import control circuit modulating bacterial development regulates protein phosphatases of the phosphorelay. Proc Natl Acad Sci U S A 94: 8612–8617.
- 25. Perego M, Hoch J. A (1996) Cell-cell communication regulates the effects of protein aspartate phosphatases on the phosphorelay controlling development in Bacillus subtilis. Proc Natl Acad Sci U S A 93: 1549–1553.
- 26. Main E. R, Xiong Y, Cocco M. J, D'Andrea L, Regan L (2003) Design of stable alpha-helical arrays from an idealized TPR motif. Structure 11: 497–508.
- 27. Hobbs C. A, Bobay B. G, Thompson R. J, Perego M, Cavanagh J (2010) NMR solution structure and DNA-binding model of the DNA-binding domain of competence protein A. J Mol Biol 398: 248–263.
- 28. Bogan A. A, Thorn K. S (1998) Anatomy of hot spots in protein interfaces. J Mol Biol 280: 1–9.
- 29. Mirouze N, Prepiak P, Dubnau D (2011) Fluctuations in spo0A transcription control rare developmental transitions in bacillus subtilis. PLoS Genet 7: e1002048. doi:10.1371/journal.pgen.1002048.
- 30. Griffith K. L, Grossman A. D (2008) A degenerate tripartite DNA-binding site required for activation of ComA-dependent quorum response gene expression in Bacillus subtilis. J Mol Biol 381: 261–275.
- 31. Leon E, Navarro-Aviles G, Santiveri C. M, Flores-Flores C, Rico M, et al. (2010) A bacterial antirepressor with SH3 domain topology mimics operator DNA in sequestering the repressor DNA recognition helix. Nucleic Acids Res 38: 5226–5241.
- 32. Chai Y, Zhu J, Winans S. C (2001) TrlR, a defective TraR-like protein of Agrobacterium tumefaciens, blocks TraR function in vitro by forming inactive TrlR:TraR dimers. Mol Microbiol 40: 414–421.
- 33. Jung A, Reinstein J, Domratcheva T, Shoeman R. L, Schlichting I (2006) Crystal structures of the AppA BLUF domain photoreceptor provide insights into blue light-mediated signal transduction. J Mol Biol 362: 717–732.
- 34. Bernhards R. C, Jing X, Vogelaar N. J, Robinson H, Schubot F. D (2009) Structural evidence suggests that antiactivator ExsD from Pseudomonas aeruginosa is a DNA binding protein. Protein Sci 18: 503–513.
- 35. Chen G, Jeffrey P. D, Fuqua C, Shi Y, Chen L (2007) Structural basis for antiactivation in bacterial quorum sensing. Proc Natl Acad Sci U S A 104: 16474–16479.
- 36. Masuda S, Bauer C. E (2002) AppA is a blue light photoreceptor that antirepresses photosynthesis gene expression in Rhodobacter sphaeroides. Cell 110: 613–623.
- 37. Brutinel E. D, Vakulskas C. A, Yahr T. L (2009) Functional domains of ExsA, the transcriptional activator of the Pseudomonas aeruginosa type III secretion system. J Bacteriol 191: 3811–3821.
- 38. Thibault J, Faudry E, Ebel C, Attree I, Elsen S (2009) Anti-activator ExsD forms a 1:1 complex with ExsA to inhibit transcription of type III secretion operons. J Biol Chem 284: 15762–15770.
- 39. Aravind L, Anantharaman V, Balaji S, Babu M. M, Iyer L. M (2005) The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 29: 231–262.
- 40. Galperin M. Y (2010) Diversity of structure and function of response regulator output domains. Curr Opin Microbiol 13: 150–159.
- 41. Maris A. E, Sawaya M. R, Kaczor-Grzeskowiak M, Jarvis M. R, Bearson S. M, et al. (2002) Dimerization allows DNA target site recognition by the NarL response regulator. Nat Struct Biol 9: 771–778.
- 42. Putnam C. D, Tainer J. A (2005) Protein mimicry of DNA and pathway regulation. DNA Repair 4: 1410–1420.
- 43. Baker N. A, Sept D, Joseph S, Holst M. J, McCammon J. A (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A 98: 10037–10041.
- 44. Ulrich L. E, Zhulin I. B (2010) The MiST2 database: a comprehensive genomics resource on microbial signal transduction. Nucleic Acids Res 38: D401–D407.
- 45. Vannini A, Volpari C, Gargioli C, Muraglia E, Cortese R, et al. (2002) The crystal structure of the quorum sensing protein TraR bound to its autoinducer and target DNA. EMBO J 21: 4393–4401.
- 46. Wisedchaisri G, Wu M, Rice A. E, Roberts D. M, Sherman D. R, et al. (2005) Structures of mycobacterium tuberculosis DosR and DosR-DNA complex involved in gene activation during adaptation to hypoxic latency. J Mol Biol 354: 630–641.
- 47. Serizawa M, Sekiguchi J (2005) The Bacillus subtilis YdfHI two-component system regulates the transcription of ydfJ, a member of the RND superfamily. Microbiology 151: 1769–1778.
- 48. Ishikawa S, Core L, Perego M (2002) Biochemical characterization of aspartyl phosphate phosphatase interaction with a phosphorylated response regulator and its inhibition by a pentapeptide. J Biol Chem 277: 20483–20489.
- 49. Declerck N, Bouillaut L, Chaix D, Rugani N, Slamti L, et al. (2007) Structure of PlcR: insights into virulence regulation and evolution of quorum sensing in Gram-positive bacteria. Proc Natl Acad Sci U S A 104: 18490–18495.
- 50. Han J, Lynne A. M, David D. E, Nayak R, Foley S. L (2011) Sequencing of plasmids from a multi-antimicrobial resistant Salmonella enterica serovar Dublin strain. Food Res Int. doi:10.1016/j.foodres.2011.1004.1016.
- 51. Shi K, Brown C. K, Gu Z. Y, Kozlowicz B. K, Dunny G. M, et al. (2005) Structure of peptide sex pheromone receptor PrgX and PrgX/pheromone complexes and regulation of conjugation in Enterococcus faecalis. Proc Natl Acad Sci U S A 102: 18596–18601.
- 52. Rocha-Estrada J, Aceves-Diez A. E, Guarneros G, de la Torre M (2010) The RNPP family of quorum-sensing proteins in Gram-positive bacteria. Appl Microbiol Biotechnol 87: 913–923.
- 53. Bongiorni C, Stoessel R, Shoemaker D, Perego M (2006) Rap phosphatase of virulence plasmid pXO1 inhibits Bacillus anthracis sporulation. J Bacteriol 188: 487–498.
- 54. Aceves-Diez A. E, Robles-Burgueno R, de la Torre M (2007) SKPDT is a signaling peptide that stimulates sporulation and cry1Aa expression in Bacillus thuringiensis but not in Bacillus subtilis. Appl Microbiol Biotechnol 76: 203–209.
- 55. Otwinowski Z, Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. In: Charles WCarter Jr, editor. Methods enzymol. Academic Press. pp. 307–326.
- 56. McCoy A. J, Grosse-Kunstleve R. W, Adams P. D, Winn M. D, Storoni L. C, et al. (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658–674.
- 57. Vagin A. A, Steiner R. A, Lebedev A. A, Potterton L, McNicholas S, et al. (2004) REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr D Biol Crystallogr 60: 2184–2195.
- 58. Perrakis A, Morris R, Lamzin V. S (1999) Automated protein model building combined with iterative structure refinement. Nat Struct Biol 6: 458–463.
- 59. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
- 60. Adams P. D, Afonine P. V, Bunkoczi G, Chen V. B, Davis I. W, et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213–221.
- 61. Hutchinson E. G, Thornton J. M (1996) PROMOTIF–a program to identify and analyze structural motifs in proteins. Protein Sci 5: 212–220.
- 62. Lovell S. C, Davis I. W, Arendall W. B 3rd, de Bakker P. I, Word J. M, et al. (2003) Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50: 437–450.
- 63. DeLano W. L (2002) The PyMOL Molecular Graphics System. DeLano Scientific, San Carlos, CA, USA.
- 64. Johnson M. L, Correia J. J, Yphantis D. A, Halvorson H. R (1981) Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys J 36: 575–588.
- 65. Laue T. M, Shah B. D, Ridgeway T. M, Pelletier S. L (1992) Computer-aided interpretation of analytical sedimentation data for proteins. In: Harding S. E, Rowe A. J, Horton J. C, editors. Analytical ultracentrifugation in biochemistry and polymer science. Cambridge, United Kingdom: Royal Society of Chemistry. pp. 90–125.
- 66. Albano M, Hahn J, Dubnau D (1987) Expression of competence genes in Bacillus subtilis. J Bacteriol 169: 3110–3117.
- 67. Wallace A. C, Laskowski R. A, Thornton J. M (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8: 127–134.
- 68. McQuade R. S, Comella N, Grossman A. D (2001) Control of a family of phosphatase regulatory genes (phr) by the alternate sigma factor sigma-H of Bacillus subtilis. J Bacteriol 183: 4905–4909.